Solve Therapeutics
Financing Round
- Series A
Round Led or Co-led By SymBiosis
Solve Therapeutics is a clinical-stage biopharmaceutical company developing next-generation antibody-based therapies for cancer with high unmet need. Its pipeline includes highly selective antibody-drug conjugates (ADCs) enabled by its proprietary CloakLink⢠hydrophilic linker technology.
